Brand Vs. Generic Supreme Court Fight: Does Sale Of Secret Invention Bar Its Patenting?

In case with potentially broad ramifications for biopharma partnerships, high court will hear arguments Dec. 4 on whether America Invents Act changed the "on-sale bar" to patentability to allow inventions that are sold to be patented if their details are not publicly disclosed.

US Supreme Court building facade with words Equal Justice

The US Supreme Court is to decide whether the America Invents Act (AIA) of 2011 revised the "on-sale bar" provision of patent law so an invention that is sold can be patented so long as its details are not publicly disclosed.

The outcome of the case, Helsinn Healthcare SA v. Teva Pharmaceuticals USA Inc., could alter what constitutes prior art...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet